Suchergebnisse

AbbVie ABBV is set to report first-quarter 2026 results on April 29, with investor focus likely to remain on its immunology segment. Following the loss of exclusivity (LoE) for its flagship drug

Coherent Corp.’s COHR stock has skyrocketed 379.3% over the past year, outperforming the industry's 29.4% growth and the Zacks S&P 500 Composite’s 35.6% rally.

1-Year Share Price Performance

Image

Celestica, Inc. CLS shares have skyrocketed 262.3% in the past year compared with the Electronics - Manufacturing Services industry’s growth of 133.3%. The stock has outperformed the Zacks Computer

Dave Inc. DAVE stock has registered explosive growth of 116.2% over the past year, outperforming the industry's 28.3% rally and the Zacks S&P 500 composite's 30.8% growth.

1-Year Share Price

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different